ME Group International plc (LSE: MEGP), the instant-service equipment group, is pleased to announce it has extended its existing relationship with WM Morrisons Supermarket Limited (“Morrisons”), one ...

SeeYouSpaceCowboy’s trans lead vocalist Connie Sgarbossa is officially leaving the band over ... The posts came amid controversy over the group’s decision to tour with an artist who had previously ...

Police are hunting an early morning robber who punched a shop worker in the face. The raider struck shortly after the member of staff opened Morrisons Daily convenience store on King Edwards Drive ...

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...

With SeeYouSpaceCowboy facing backlash from the announcement of their tour with Dance Gavin Dance, SeeYouSpaceCowboy vocalist Connie Sgarbossa made a pair of tweets yesterday that seemed to be related ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda for patient convenience as the company approaches a steep patent ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...